Search

Start Over Authors Whittington, Melanie D., author

2. Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary

Author(s):
Tice, Jeffrey A., author
Whittington, Melanie D., author
Fluetsch, Noemi, author
Zapata, Lorenzo Villa, author
Mendola, Nicolas D., author
Chapman, Rick M., author
Campbell, Jonathan D., author
Pearson, Steven D., author
Bradt, Pamela, author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 11, 2020
Subject(s):
Behavior Therapy
Digital Technology
Opiate Substitution Treatment
Opioid-Related Disorders -- therapy
United States

3. Special assessment of outpatient treatments for COVID-19: nirmatrelvir/ritonavir (Paxlovid) health-benefit price benchmark update

Author(s):
Whittington, Melanie D., author
Campbell, Jonathan D., author
Richardson, Marina, author
Nhan, Emily, author
McKenna, Avery, author
Agboola, Foluso, author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, December 20, 2022
Subject(s):
Ambulatory Care -- economics
Antiviral Agents -- economics
COVID-19 Drug Treatment
Drug Combinations
Drug Costs
Lactams
Leucine
Nitriles
Proline
Ritonavir
United States

4. Oral and monoclonal antibody treatments for relapsing forms of multiple sclerosis: effectiveness and value : final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Nikitin, Dmitriy, author
Agboola, Foluso, author
McKenna, Avery, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Campbell, Jonathan D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, February 21, 2023
Subject(s):
Antibodies, Monoclonal -- therapeutic use
Multiple Sclerosis, Relapsing-Remitting -- drug therapy
Treatment Outcome
Administration, Oral
United States

5. Lecanemab for early Alzheimer’s disease: final evidence report

Author(s):
Lin, Grace A., author
Whittington, Melanie D., author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Agboola, Foluso, author
Herron-Smith, Serina, author
Pearson, Steven D., author
Rind, David, (Of Institute for Clinical and Economic Review), author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, April 17, 2023
Subject(s):
Alzheimer Disease -- drug therapy
Antibodies, Monoclonal, Humanized
United States

7. Mavacamten for hypertrophic cardiomyopathy: effectiveness and value : final evidence report and meeting summary

Author(s):
Wasfy, Jason H., author
Walton, Surrey M., author
Beinfeld, Molly, author
Nhan, Emily, author
Sarker, Jyotirmoy, author
Whittington, Melanie D., author
Pearson, Steven D., author
Rind, David M., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, November 16, 2021
Subject(s):
Cardiac Myosins -- antagonists & inhibitors
Cardiomyopathy, Hypertrophic -- drug therapy
United States

8. Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary

Author(s):
Yeung, Kai, 1981- author
Whittington, Melanie D., author
Beinfeld, Molly, author
Mohammed, Rasheed, author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Nhan, Emily, author
Fluetsch, Noemi, author
Richardson, Marina, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 10, 2022
Subject(s):
Ambulatory Care
COVID-19 Drug Treatment
Home Infusion Therapy
United States